Genomic Valley Biotech standalone net profit rises 650.00% in the September 2024 quarter
Sales rise 200.00% to Rs 0.21 crore
Net profit of Genomic Valley Biotech rose 650.00% to Rs 0.15 crore in the quarter ended September 2024 as against Rs 0.02 crore during the previous quarter ended September 2023. Sales rose 200.00% to Rs 0.21 crore in the quarter ended September 2024 as against Rs 0.07 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales0.210.07 200 OPM %66.6728.57 -PBDT0.150.02 650 PBT0.150.02 650 NP0.150.02 650Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 08 2024 | 7:41 AM IST